9 RECOMMENDATIONS 25 The overall recommendation of the Confidentiality Committee is that the IPA foster and strengthen a culture of confidentiality in every aspect of its operations. This will require an approach in which everyone has a responsibility to protect confidentiality wherever the need arises. In addition, we make the following particular recommendations: 9.1 Protection of patients in the use of clinical material At the institutional level The IPA should encourage its constituent organisations to: ● Include a seminar about confidentiality as part of training, promoting the presentation and discussion of clinical material with in-depth consideration of the following: advantages and disadvantages of the different ways in which confidentiality might be protected in the sharing of clinical material: disguise; informed consent from a psychoanalytic point of view; amalgamating case material; the role of multiple or anonymous authorship; and so on. ● Make the protection of confidentiality an issue of regular concern each time members or candidates present clinical material in society meetings, seminars, working groups, and so on and introduce periodic workshops on the issue (see also 9.2 below). ● Introduce workshops about safe and appropriate standards of record-keeping. Presentation of clinical material in congresses and other scientific events 26 To use clinical material in presentations, the following steps should be taken: ● Prepare a statement about confidentiality in calls for papers. In particular, presenting analysts should be alerted to some of the negative consequences of poorly controlled confidentiality on patients and analysts. They should also be advised to consult their peers if they wish to share clinical material in any setting. Prior consultation with colleagues should be encouraged regardless of the method used to protect patients. ● Review submitted papers carefully. The programme or scientific committee should review each submission containing clinical material and – when in doubt – ask for feedback from a select team of advisors about the protection of confidentiality. When clinical material cannot be changed, as in the narration of a dream, disguise, anonymization, or a carefully considered request for permission might be used to 25 The numbering of these recommendations differs from that used in the April 2018 draft version of the report because it proved impractical to maintain strict correspondence with the numbering of the preceding sections. 26 A preliminary version of some of these recommendations was accepted by the Officers on behalf of the Board in June and July 2017.
34
Made with FlippingBook - professional solution for displaying marketing and sales documents online